Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Scaffolding the Attention-Deficit/Hyperactivity Disorder Brain Using Random Noise Stimulation: A Randomized Controlled Trial
Child Neurology and Developmental Neurology
Child Neurology and Developmental Neurology Posters (7:00 AM-5:00 PM)
019
We examined whether neurostimulation protocols, which have been shown to yield long-term effect when combined with cognitive training, could benefit children with attention deficit hyperactivity disorder (ADHD), the most common neurodevelopmental disorder in childhood. 
Various methods have been attempted to ameliorate neuro-psychiatric conditions. One of the attractive ideas is to develop interventions to create a lasting, rather than only an immediate, effect. 

We used a randomized double-blind active-controlled crossover study of 19 unmedicated children (aged 7–12 years old) with ADHD, who received either transcranial direct current stimulation (tDCS) or random noise stimulation (tRNS) while completing executive functions training. tDCS was examined in multiple ADHD studies and has been highlighted as a promising method for treating neuropsychological deficits. 

For our primary outcome, tRNS yielded a clinical improvement as indicated by the reduced ADHD rating-scale score from baseline, and in comparison to the changes observed in tDCS [β=-.42, 95% CI (-.77, -.07)]. The effect of brain stimulation one week after completion of treatment yielded further improvement [β=-.19, 95% CI (-.37, -.01)], suggesting a neuroplasticity-related effect. Finally, tRNS improved working memory compared to tDCS [β=.33, 95% CI (.02, .64)], and a larger tRNS effect on ADHD rating-scale was predicted for those who showed the greatest improvement in working memory. 

Our results provide a promising direction toward a novel intervention in ADHD, which is shown to have a lasting effect via the modulating of neuroplasticity, rather than a merely immediate effect as was shown for in previous medical interventions.

Authors/Disclosures
Itai Berger, MD (Assuta Ashdod University Hospital)
PRESENTER
Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Berger has received personal compensation in the range of $0-$499 for serving as a Consultant for Medison. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file